Skip to content
HowShorted

Danimer Scientific, Inc. short interest in 2023

In 2023, Danimer Scientific, Inc.'s disclosed short interest ran from 17.27% of shares outstanding on 13 Jan 2023 to 21.40% on 29 Dec 2023, a change of +4.13 percentage points. The year's high was 21.40% on 29 Dec 2023 and its low 13.88% on 31 Oct 2023, averaging 15.84% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.92 days on 13 Oct 2023. Full history: Danimer Scientific, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for Danimer Scientific, Inc. in 2023

2023 in figures

Start of year
17.27% (13 Jan 2023)
End of year
21.40% (29 Dec 2023)
Change
+4.13 pp
High
21.40% (29 Dec 2023)
Low
13.88% (31 Oct 2023)
Average
15.84%
Highest days to cover
25.92 (13 Oct 2023)
SEC filings marked
9

Every report in 2023

Danimer Scientific, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 202317.27%14.91
31 Jan 202316.75%15.39
15 Feb 202314.65%16.64
28 Feb 202316.07%6.34
15 Mar 202316.49%15.51
31 Mar 202316.26%10.23results (8-K), 10-K filed, results (8-K)
14 Apr 202315.49%6.42
28 Apr 202315.50%10.82
15 May 202315.07%22.7210-Q filed, results (8-K)
31 May 202315.23%19.40
15 Jun 202314.41%14.18
30 Jun 202315.32%14.60
14 Jul 202316.76%17.48
31 Jul 202315.19%19.41
15 Aug 202315.35%15.9910-Q filed, results (8-K)
31 Aug 202315.14%15.45
15 Sep 202315.76%23.21
29 Sep 202314.68%22.76
13 Oct 202314.19%25.92
31 Oct 202313.88%17.19
15 Nov 202315.99%16.8010-Q filed, results (8-K)
30 Nov 202317.39%9.11
15 Dec 202315.89%13.96
29 Dec 202321.40%13.87

See also: Danimer Scientific, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.